Related Experiment Videos
Immunointervention in autoimmune diseases from cellular selectivity to autoantigen specificity
1Immunology Department, Hôpital Necker, Paris, France.
Journal of Autoimmunity
|April 1, 1992
Summary
Immunosuppressive therapies help autoimmune diseases but cause relapses and complications. New strategies focus on faster, selective treatments like peptide therapy and tolerance induction for better autoimmune disease management.
Area of Science:
- Immunology
- Pharmacology
- Autoimmune Diseases
Background:
- Immunosuppressive agents are effective for autoimmune diseases.
- Treatment cessation often leads to disease relapse.
- Long-term immunosuppression carries risks of complications.
Purpose of the Study:
- To explore novel therapeutic strategies for autoimmune diseases.
- To develop treatments with faster and more selective intervention.
- To enable earlier initiation of therapy for autoimmune conditions.
Main Methods:
- Review of current clinical and experimental approaches.
- Focus on chemical agents and monoclonal antibodies in clinical practice.
- Investigation of experimental peptide therapy (autoantigen, T cell receptor) and tolerance induction.
Main Results:
- Current clinical treatments include new chemicals and monoclonal antibodies.
- Experimental research emphasizes peptide therapy and tolerance induction.
- These novel approaches aim to overcome limitations of existing therapies.
Conclusions:
- New therapeutic avenues are crucial for managing autoimmune diseases.
- Peptide therapy and tolerance induction show promise in experimental settings.
- Future research should focus on selective and early-onset interventions for autoimmune disorders.